According to ORIC Pharmaceuticals
's latest financial reports the company has C$0.36 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | C$0.36 B | 33.02% |
2023-12-31 | C$0.27 B | -1.35% |
2022-12-31 | C$0.27 B | -7.32% |
2021-12-31 | C$0.30 B | -19.32% |
2020-12-31 | C$0.37 B | 221.49% |
2019-12-31 | C$0.11 B | 100.5% |
2018-12-31 | C$58.07 M |